Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.07098612 |
2 | negative regulation of cell killing (GO:0031342) | 7.07098612 |
3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.38260956 |
4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.38260956 |
5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.27203087 |
6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.27203087 |
7 | modulation by symbiont of host immune response (GO:0052553) | 5.27203087 |
8 | positive regulation by symbiont of host defense response (GO:0052509) | 5.27203087 |
9 | modulation by symbiont of host defense response (GO:0052031) | 5.27203087 |
10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.27203087 |
11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.15973919 |
12 | detection of other organism (GO:0098543) | 4.81958401 |
13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.73870579 |
14 | response to interleukin-15 (GO:0070672) | 4.58511997 |
15 | detection of bacterium (GO:0016045) | 4.57146825 |
16 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.48739714 |
17 | macrophage activation involved in immune response (GO:0002281) | 4.38737779 |
18 | neutrophil activation involved in immune response (GO:0002283) | 4.34714425 |
19 | leukocyte aggregation (GO:0070486) | 4.34489785 |
20 | valine metabolic process (GO:0006573) | 4.32621103 |
21 | cellular extravasation (GO:0045123) | 4.27275187 |
22 | negative T cell selection (GO:0043383) | 4.23530713 |
23 | cellular response to interleukin-15 (GO:0071350) | 4.23311460 |
24 | negative thymic T cell selection (GO:0045060) | 4.22747311 |
25 | detection of external biotic stimulus (GO:0098581) | 4.18914374 |
26 | detection of molecule of bacterial origin (GO:0032490) | 4.09336923 |
27 | negative regulation of T cell mediated immunity (GO:0002710) | 4.07423263 |
28 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.05111421 |
29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.95449204 |
30 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.92618738 |
31 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.91872443 |
32 | regulation of sequestering of triglyceride (GO:0010889) | 3.82978461 |
33 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.78567396 |
34 | definitive hemopoiesis (GO:0060216) | 3.77630495 |
35 | neutrophil activation (GO:0042119) | 3.77557393 |
36 | microglial cell activation (GO:0001774) | 3.77467473 |
37 | B cell receptor signaling pathway (GO:0050853) | 3.76898894 |
38 | low-density lipoprotein particle clearance (GO:0034383) | 3.71155498 |
39 | response to peptidoglycan (GO:0032494) | 3.69383792 |
40 | fatty acid transmembrane transport (GO:1902001) | 3.68975597 |
41 | positive T cell selection (GO:0043368) | 3.67489063 |
42 | activated T cell proliferation (GO:0050798) | 3.66570817 |
43 | negative regulation of interleukin-12 production (GO:0032695) | 3.63923986 |
44 | response to host immune response (GO:0052572) | 3.63667257 |
45 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.63667257 |
46 | carnitine shuttle (GO:0006853) | 3.63435118 |
47 | detection of biotic stimulus (GO:0009595) | 3.63235758 |
48 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.60596546 |
49 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.55349196 |
50 | negative regulation of granulocyte differentiation (GO:0030853) | 3.55296059 |
51 | T cell selection (GO:0045058) | 3.54468746 |
52 | respiratory burst (GO:0045730) | 3.53552378 |
53 | regulation of T cell tolerance induction (GO:0002664) | 3.50764499 |
54 | regulation of cholesterol storage (GO:0010885) | 3.45407228 |
55 | regulation of tolerance induction (GO:0002643) | 3.44395633 |
56 | positive regulation of histone deacetylation (GO:0031065) | 3.41895242 |
57 | T cell migration (GO:0072678) | 3.41420678 |
58 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.40492245 |
59 | response to host (GO:0075136) | 3.40492245 |
60 | response to host defenses (GO:0052200) | 3.40492245 |
61 | regulation of gamma-delta T cell activation (GO:0046643) | 3.36793211 |
62 | neutrophil mediated immunity (GO:0002446) | 3.36063426 |
63 | immunoglobulin mediated immune response (GO:0016064) | 3.34982962 |
64 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.34455219 |
65 | granulocyte activation (GO:0036230) | 3.33327953 |
66 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.32067891 |
67 | macrophage activation (GO:0042116) | 3.31791656 |
68 | thymic T cell selection (GO:0045061) | 3.30168692 |
69 | dendritic cell migration (GO:0036336) | 3.28221418 |
70 | myeloid cell activation involved in immune response (GO:0002275) | 3.27966067 |
71 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.26979576 |
72 | negative regulation of protein autophosphorylation (GO:0031953) | 3.24165215 |
73 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.23393994 |
74 | regulation of mast cell degranulation (GO:0043304) | 3.23259574 |
75 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.23095286 |
76 | response to muramyl dipeptide (GO:0032495) | 3.21896501 |
77 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.21664857 |
78 | dendritic cell chemotaxis (GO:0002407) | 3.21346931 |
79 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.19527390 |
80 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.18748950 |
81 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.18748950 |
82 | growth hormone receptor signaling pathway (GO:0060396) | 3.18188604 |
83 | positive regulation of granulocyte differentiation (GO:0030854) | 3.15627824 |
84 | brown fat cell differentiation (GO:0050873) | 3.15338459 |
85 | tolerance induction (GO:0002507) | 3.14777630 |
86 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.12456077 |
87 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.10814999 |
88 | regulation of regulatory T cell differentiation (GO:0045589) | 3.10443832 |
89 | negative regulation of type 2 immune response (GO:0002829) | 3.10060491 |
90 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.07727151 |
91 | positive regulation of mast cell activation (GO:0033005) | 3.03884737 |
92 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.03438147 |
93 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.03438147 |
94 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.02518210 |
95 | positive regulation of tolerance induction (GO:0002645) | 3.01635533 |
96 | fatty acid beta-oxidation (GO:0006635) | 2.99402732 |
97 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.98679613 |
98 | tricarboxylic acid metabolic process (GO:0072350) | 2.98447314 |
99 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.96302793 |
100 | myeloid leukocyte mediated immunity (GO:0002444) | 2.94697012 |
101 | apoptotic cell clearance (GO:0043277) | 2.93989641 |
102 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.93599226 |
103 | cellular response to growth hormone stimulus (GO:0071378) | 2.93486391 |
104 | regulation of leukocyte degranulation (GO:0043300) | 2.89993872 |
105 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.89670917 |
106 | negative regulation of adaptive immune response (GO:0002820) | 2.88713782 |
107 | defense response to protozoan (GO:0042832) | 2.87508814 |
108 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.86528594 |
109 | carnitine transmembrane transport (GO:1902603) | 2.82426741 |
110 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.81582843 |
111 | white fat cell differentiation (GO:0050872) | 2.79300451 |
112 | positive regulation of B cell differentiation (GO:0045579) | 2.78008089 |
113 | fibroblast migration (GO:0010761) | 2.76775636 |
114 | intracellular lipid transport (GO:0032365) | 2.68893617 |
115 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.67337843 |
116 | regulation of fatty acid oxidation (GO:0046320) | 2.66100824 |
117 | carnitine transport (GO:0015879) | 2.65634142 |
118 | amino-acid betaine transport (GO:0015838) | 2.65634142 |
119 | positive regulation of protein deacetylation (GO:0090312) | 2.64467515 |
120 | lipid storage (GO:0019915) | 2.62749273 |
121 | negative regulation of stress fiber assembly (GO:0051497) | 2.62539580 |
122 | surfactant homeostasis (GO:0043129) | 2.62388501 |
123 | fatty acid oxidation (GO:0019395) | 2.61829131 |
124 | morphogenesis of an endothelium (GO:0003159) | 2.59909640 |
125 | endothelial tube morphogenesis (GO:0061154) | 2.59909640 |
126 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.57931013 |
127 | lipid oxidation (GO:0034440) | 2.54334456 |
128 | biotin metabolic process (GO:0006768) | 2.53383175 |
129 | positive regulation of fatty acid oxidation (GO:0046321) | 2.52583002 |
130 | basement membrane organization (GO:0071711) | 2.50906379 |
131 | endothelial cell chemotaxis (GO:0035767) | 2.49623435 |
132 | transcytosis (GO:0045056) | 2.49492704 |
133 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.48344229 |
134 | megakaryocyte development (GO:0035855) | 2.48301488 |
135 | positive regulation of p38MAPK cascade (GO:1900745) | 2.45351788 |
136 | branched-chain amino acid metabolic process (GO:0009081) | 2.45051939 |
137 | fatty acid catabolic process (GO:0009062) | 2.44058217 |
138 | hemidesmosome assembly (GO:0031581) | 2.43512437 |
139 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.43188890 |
140 | negative regulation of phagocytosis (GO:0050765) | 2.42738397 |
141 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.41877358 |
142 | cellular response to zinc ion (GO:0071294) | 2.41511021 |
143 | triglyceride catabolic process (GO:0019433) | 2.39293772 |
144 | negative regulation of lipid storage (GO:0010888) | 2.37140823 |
145 | lipid particle organization (GO:0034389) | 2.36967723 |
146 | positive thymic T cell selection (GO:0045059) | 2.34626671 |
147 | response to laminar fluid shear stress (GO:0034616) | 2.33309270 |
148 | COPI coating of Golgi vesicle (GO:0048205) | 2.32890719 |
149 | Golgi transport vesicle coating (GO:0048200) | 2.32890719 |
150 | blood vessel maturation (GO:0001955) | 2.32383437 |
151 | hepatocyte apoptotic process (GO:0097284) | 2.31641844 |
152 | epithelial cell-cell adhesion (GO:0090136) | 2.30853802 |
153 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.29698127 |
154 | response to type I interferon (GO:0034340) | 2.29107460 |
155 | keratan sulfate catabolic process (GO:0042340) | 2.28876883 |
156 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.28751954 |
157 | response to interferon-alpha (GO:0035455) | 2.28312889 |
158 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.25934038 |
159 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.23791485 |
160 | leukocyte tethering or rolling (GO:0050901) | 2.22976733 |
161 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.22768318 |
162 | type I interferon signaling pathway (GO:0060337) | 2.18171072 |
163 | cellular response to type I interferon (GO:0071357) | 2.18171072 |
164 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.17923188 |
165 | pentose-phosphate shunt (GO:0006098) | 2.17542845 |
166 | germ cell migration (GO:0008354) | 2.17489271 |
167 | regulation of B cell differentiation (GO:0045577) | 2.17338210 |
168 | regulation of erythrocyte differentiation (GO:0045646) | 2.17056065 |
169 | ribosomal small subunit assembly (GO:0000028) | 2.16988202 |
170 | angiogenesis involved in wound healing (GO:0060055) | 2.16884714 |
171 | positive regulation of lipid storage (GO:0010884) | 2.16701463 |
172 | ovulation from ovarian follicle (GO:0001542) | 2.16682844 |
173 | regulation of p38MAPK cascade (GO:1900744) | 2.16659659 |
174 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.16248583 |
175 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.14321395 |
176 | regulation of response to interferon-gamma (GO:0060330) | 2.14089740 |
177 | macrophage differentiation (GO:0030225) | 2.13583555 |
178 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.13266898 |
179 | pinocytosis (GO:0006907) | 2.13145953 |
180 | negative regulation of innate immune response (GO:0045824) | 2.13100439 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.12353288 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.18486850 |
3 | GATA1_22025678_ChIP-Seq_K562_Human | 2.99361168 |
4 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.91415648 |
5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.74849750 |
6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.73642889 |
7 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.72446530 |
8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.71504214 |
9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.67891794 |
10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.38899743 |
11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.36904118 |
12 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.25730572 |
13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.22569711 |
14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.20766795 |
15 | MYC_22102868_ChIP-Seq_BL_Human | 2.16697129 |
16 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.15088520 |
17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.11188849 |
18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.02652695 |
19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.97734987 |
20 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.92453165 |
21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.92211655 |
22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.91830739 |
23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.91752989 |
24 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89629950 |
25 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.89268350 |
26 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.84741647 |
27 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.83585629 |
28 | * MAF_26560356_Chip-Seq_TH1_Human | 1.80983411 |
29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.80365664 |
30 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.80148920 |
31 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.79796394 |
32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.78435633 |
33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.77960904 |
34 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.77166980 |
35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.75700122 |
36 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.70937308 |
37 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.70332092 |
38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.67263051 |
39 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.66908411 |
40 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.60124550 |
41 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.59649318 |
42 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59362907 |
43 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.57880994 |
44 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57044433 |
45 | MYB_26560356_Chip-Seq_TH2_Human | 1.56980292 |
46 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.56474835 |
47 | UTX_26944678_Chip-Seq_JUKART_Human | 1.54193579 |
48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.53842875 |
49 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.52819168 |
50 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50778176 |
51 | MYB_26560356_Chip-Seq_TH1_Human | 1.42728728 |
52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42205248 |
53 | GATA1_19941826_ChIP-Seq_K562_Human | 1.41864253 |
54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.41787913 |
55 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.41759660 |
56 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.41554849 |
57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.39965366 |
58 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.39843861 |
59 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.39550003 |
60 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.39339222 |
61 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.39258858 |
62 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.35340868 |
63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.33743796 |
64 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.32976236 |
65 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31911135 |
66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31566698 |
67 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.31494549 |
68 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.31143423 |
69 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.30337992 |
70 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.26606725 |
71 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.25656116 |
72 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.25656116 |
73 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.25287949 |
74 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.24739418 |
75 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.24497516 |
76 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.24137358 |
77 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.23839641 |
78 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.23577877 |
79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23057367 |
80 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22213118 |
81 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22063802 |
82 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.21763190 |
83 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21739429 |
84 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21675089 |
85 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21317652 |
86 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21185469 |
87 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19805450 |
88 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.18831500 |
89 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.18829821 |
90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18645018 |
91 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.17164298 |
92 | GATA2_19941826_ChIP-Seq_K562_Human | 1.16777518 |
93 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.15842975 |
94 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.15734288 |
95 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15161780 |
96 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.15013168 |
97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13518045 |
98 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12831537 |
99 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12541282 |
100 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12175803 |
101 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11492741 |
102 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10924970 |
103 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10743946 |
104 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10575658 |
105 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.10243862 |
106 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.08809182 |
107 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.07354205 |
108 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04862007 |
109 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04479354 |
110 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04334994 |
111 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03948896 |
112 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03739083 |
113 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03045735 |
114 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01852963 |
115 | * MAF_26560356_Chip-Seq_TH2_Human | 1.00652089 |
116 | ATF3_27146783_Chip-Seq_COLON_Human | 0.98934009 |
117 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98894771 |
118 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97990357 |
119 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96278588 |
120 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95838520 |
121 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.95726176 |
122 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95512034 |
123 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.93232449 |
124 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91229279 |
125 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.89949557 |
126 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85761186 |
127 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84306505 |
128 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83871154 |
129 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83356101 |
130 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81106439 |
131 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.80912725 |
132 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.79799035 |
133 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.78350333 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005670_abnormal_white_adipose | 3.36060750 |
2 | MP0003191_abnormal_cellular_cholesterol | 2.60266141 |
3 | MP0005666_abnormal_adipose_tissue | 2.55003348 |
4 | MP0004185_abnormal_adipocyte_glucose | 2.31536732 |
5 | MP0003300_gastrointestinal_ulcer | 2.26942427 |
6 | * MP0004130_abnormal_muscle_cell | 2.22466983 |
7 | MP0003724_increased_susceptibility_to | 2.17891553 |
8 | MP0008260_abnormal_autophagy | 2.09649619 |
9 | MP0002166_altered_tumor_susceptibility | 2.02840641 |
10 | MP0006054_spinal_hemorrhage | 2.02043669 |
11 | MP0008438_abnormal_cutaneous_collagen | 1.97295416 |
12 | MP0004381_abnormal_hair_follicle | 1.85373208 |
13 | MP0005375_adipose_tissue_phenotype | 1.84821309 |
14 | MP0010368_abnormal_lymphatic_system | 1.84185965 |
15 | MP0003705_abnormal_hypodermis_morpholog | 1.82989714 |
16 | MP0003566_abnormal_cell_adhesion | 1.81960222 |
17 | MP0001835_abnormal_antigen_presentation | 1.81628367 |
18 | MP0001879_abnormal_lymphatic_vessel | 1.80073978 |
19 | MP0002132_abnormal_respiratory_system | 1.74717710 |
20 | MP0009333_abnormal_splenocyte_physiolog | 1.73901227 |
21 | MP0000703_abnormal_thymus_morphology | 1.71079372 |
22 | MP0003828_pulmonary_edema | 1.68650105 |
23 | MP0002877_abnormal_melanocyte_morpholog | 1.66997673 |
24 | MP0000685_abnormal_immune_system | 1.66145713 |
25 | MP0004883_abnormal_blood_vessel | 1.64004245 |
26 | MP0005058_abnormal_lysosome_morphology | 1.62271324 |
27 | MP0005451_abnormal_body_composition | 1.57600304 |
28 | MP0009278_abnormal_bone_marrow | 1.56514210 |
29 | * MP0002429_abnormal_blood_cell | 1.51431958 |
30 | MP0003172_abnormal_lysosome_physiology | 1.45765994 |
31 | MP0000465_gastrointestinal_hemorrhage | 1.44711667 |
32 | MP0010234_abnormal_vibrissa_follicle | 1.44331290 |
33 | MP0000343_altered_response_to | 1.42673624 |
34 | MP0005464_abnormal_platelet_physiology | 1.41720684 |
35 | MP0010155_abnormal_intestine_physiology | 1.38337640 |
36 | MP0005275_abnormal_skin_tensile | 1.38029662 |
37 | MP0003436_decreased_susceptibility_to | 1.36903785 |
38 | MP0005397_hematopoietic_system_phenotyp | 1.34735874 |
39 | MP0001545_abnormal_hematopoietic_system | 1.34735874 |
40 | MP0002006_tumorigenesis | 1.32715418 |
41 | MP0003690_abnormal_glial_cell | 1.32512750 |
42 | MP0002396_abnormal_hematopoietic_system | 1.31346660 |
43 | MP0002837_dystrophic_cardiac_calcinosis | 1.31016780 |
44 | MP0004084_abnormal_cardiac_muscle | 1.30368474 |
45 | MP0003045_fibrosis | 1.29390007 |
46 | MP0005671_abnormal_response_to | 1.29173168 |
47 | MP0002971_abnormal_brown_adipose | 1.28888534 |
48 | MP0002254_reproductive_system_inflammat | 1.28786539 |
49 | MP0004808_abnormal_hematopoietic_stem | 1.28389194 |
50 | MP0000013_abnormal_adipose_tissue | 1.27294056 |
51 | MP0001873_stomach_inflammation | 1.26610114 |
52 | MP0003763_abnormal_thymus_physiology | 1.25456090 |
53 | MP0004272_abnormal_basement_membrane | 1.25250097 |
54 | MP0009785_altered_susceptibility_to | 1.24850370 |
55 | MP0009764_decreased_sensitivity_to | 1.24402818 |
56 | MP0005164_abnormal_response_to | 1.23588813 |
57 | MP0002998_abnormal_bone_remodeling | 1.23487591 |
58 | MP0003183_abnormal_peptide_metabolism | 1.21508846 |
59 | MP0005167_abnormal_blood-brain_barrier | 1.19625755 |
60 | MP0000003_abnormal_adipose_tissue | 1.18674492 |
61 | MP0002277_abnormal_respiratory_mucosa | 1.17567247 |
62 | MP0001800_abnormal_humoral_immune | 1.16563655 |
63 | MP0005025_abnormal_response_to | 1.15360015 |
64 | MP0004264_abnormal_extraembryonic_tissu | 1.15111318 |
65 | MP0009115_abnormal_fat_cell | 1.14505204 |
66 | MP0010352_gastrointestinal_tract_polyps | 1.13759676 |
67 | MP0003279_aneurysm | 1.12954615 |
68 | MP0001790_abnormal_immune_system | 1.12882842 |
69 | MP0005387_immune_system_phenotype | 1.12882842 |
70 | MP0002452_abnormal_antigen_presenting | 1.12698023 |
71 | MP0005075_abnormal_melanosome_morpholog | 1.11251212 |
72 | MP0005310_abnormal_salivary_gland | 1.09565623 |
73 | MP0001533_abnormal_skeleton_physiology | 1.09337295 |
74 | MP0002419_abnormal_innate_immunity | 1.08895735 |
75 | * MP0009643_abnormal_urine_homeostasis | 1.07240185 |
76 | MP0004947_skin_inflammation | 1.05207793 |
77 | MP0002009_preneoplasia | 1.04583821 |
78 | MP0005334_abnormal_fat_pad | 1.04327537 |
79 | MP0008961_abnormal_basal_metabolism | 1.03979763 |
80 | MP0005023_abnormal_wound_healing | 1.03313192 |
81 | * MP0002420_abnormal_adaptive_immunity | 1.02764599 |
82 | * MP0001819_abnormal_immune_cell | 1.01700362 |
83 | MP0001958_emphysema | 1.01410602 |
84 | MP0010630_abnormal_cardiac_muscle | 1.00815631 |
85 | MP0001845_abnormal_inflammatory_respons | 1.00595552 |
86 | MP0002933_joint_inflammation | 1.00489320 |
87 | MP0001853_heart_inflammation | 0.99554326 |
88 | MP0002723_abnormal_immune_serum | 0.98750591 |
89 | MP0005000_abnormal_immune_tolerance | 0.98393014 |
90 | MP0002060_abnormal_skin_morphology | 0.96865603 |
91 | * MP0000609_abnormal_liver_physiology | 0.95969838 |
92 | * MP0010329_abnormal_lipoprotein_level | 0.95321817 |
93 | MP0003866_abnormal_defecation | 0.94345367 |
94 | MP0004036_abnormal_muscle_relaxation | 0.94105513 |
95 | MP0003656_abnormal_erythrocyte_physiolo | 0.91578250 |
96 | MP0008004_abnormal_stomach_pH | 0.89157642 |
97 | MP0005166_decreased_susceptibility_to | 0.89137066 |
98 | MP0002405_respiratory_system_inflammati | 0.88990200 |
99 | MP0003075_altered_response_to | 0.88830641 |
100 | MP0000767_abnormal_smooth_muscle | 0.88261800 |
101 | * MP0002398_abnormal_bone_marrow | 0.88145680 |
102 | MP0000689_abnormal_spleen_morphology | 0.87743689 |
103 | MP0008469_abnormal_protein_level | 0.87100543 |
104 | MP0000604_amyloidosis | 0.86572853 |
105 | MP0005365_abnormal_bile_salt | 0.84566141 |
106 | MP0003303_peritoneal_inflammation | 0.84486915 |
107 | MP0000249_abnormal_blood_vessel | 0.84037002 |
108 | MP0006082_CNS_inflammation | 0.83788646 |
109 | MP0003448_altered_tumor_morphology | 0.83304471 |
110 | * MP0000716_abnormal_immune_system | 0.82852911 |
111 | MP0002970_abnormal_white_adipose | 0.82637619 |
112 | MP0005390_skeleton_phenotype | 0.82443789 |
113 | * MP0002722_abnormal_immune_system | 0.81203101 |
114 | * MP0002118_abnormal_lipid_homeostasis | 0.81115202 |
115 | MP0004087_abnormal_muscle_fiber | 0.80560639 |
116 | * MP0002136_abnormal_kidney_physiology | 0.79791630 |
117 | MP0001986_abnormal_taste_sensitivity | 0.79731692 |
118 | MP0003221_abnormal_cardiomyocyte_apopto | 0.79650452 |
119 | MP0001851_eye_inflammation | 0.79359508 |
120 | * MP0005385_cardiovascular_system_phenoty | 0.79068637 |
121 | * MP0001544_abnormal_cardiovascular_syste | 0.79068637 |
122 | MP0001756_abnormal_urination | 0.79001308 |
123 | MP0003453_abnormal_keratinocyte_physiol | 0.78622148 |
124 | MP0000858_altered_metastatic_potential | 0.78132832 |
125 | * MP0009763_increased_sensitivity_to | 0.78115321 |
126 | MP0002148_abnormal_hypersensitivity_rea | 0.77538644 |
127 | MP0006138_congestive_heart_failure | 0.76627647 |
128 | MP0001663_abnormal_digestive_system | 0.73931152 |
129 | MP0002133_abnormal_respiratory_system | 0.73855889 |
130 | MP0005388_respiratory_system_phenotype | 0.73855889 |
131 | MP0003091_abnormal_cell_migration | 0.72437668 |
132 | MP0004510_myositis | 0.68898024 |
133 | MP0003795_abnormal_bone_structure | 0.65239752 |
134 | MP0000015_abnormal_ear_pigmentation | 0.64308609 |
135 | MP0009765_abnormal_xenobiotic_induced | 0.60171733 |
136 | MP0002332_abnormal_exercise_endurance | 0.57578193 |
137 | MP0002138_abnormal_hepatobiliary_system | 0.54760981 |
138 | MP0000569_abnormal_digit_pigmentation | 0.54739759 |
139 | * MP0008874_decreased_physiological_sensi | 0.52771768 |
140 | MP0003329_amyloid_beta_deposits | 0.51311413 |
141 | MP0005376_homeostasis/metabolism_phenot | 0.48968853 |
142 | * MP0004484_altered_response_of | 0.48502700 |
143 | MP0003252_abnormal_bile_duct | 0.47948828 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent bacterial skin infections (HP:0005406) | 5.52724188 |
2 | Orchitis (HP:0100796) | 5.21156465 |
3 | Optic neuritis (HP:0100653) | 4.97037142 |
4 | Retrobulbar optic neuritis (HP:0100654) | 4.97037142 |
5 | Stomatitis (HP:0010280) | 4.69487225 |
6 | Abnormality of macrophages (HP:0004311) | 4.63480164 |
7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.49322237 |
8 | Gastrointestinal infarctions (HP:0005244) | 4.39705626 |
9 | T lymphocytopenia (HP:0005403) | 4.24604688 |
10 | Recurrent fungal infections (HP:0002841) | 4.23838431 |
11 | Hematochezia (HP:0002573) | 4.01959706 |
12 | Abnormality of T cell number (HP:0011839) | 3.99060422 |
13 | Meningitis (HP:0001287) | 3.91373492 |
14 | Mediastinal lymphadenopathy (HP:0100721) | 3.89027719 |
15 | Keratoconjunctivitis sicca (HP:0001097) | 3.80051994 |
16 | Recurrent skin infections (HP:0001581) | 3.75081472 |
17 | Encephalitis (HP:0002383) | 3.68983799 |
18 | Cerebral aneurysm (HP:0004944) | 3.60589517 |
19 | Obstructive lung disease (HP:0006536) | 3.59247642 |
20 | Chronic obstructive pulmonary disease (HP:0006510) | 3.59247642 |
21 | Recurrent cutaneous fungal infections (HP:0011370) | 3.53339515 |
22 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.53339515 |
23 | Gingivitis (HP:0000230) | 3.51819040 |
24 | Keratoconjunctivitis (HP:0001096) | 3.51406961 |
25 | Vasculitis (HP:0002633) | 3.41499231 |
26 | Aortic aneurysm (HP:0004942) | 3.41155370 |
27 | Spontaneous hematomas (HP:0007420) | 3.33544588 |
28 | Chest pain (HP:0100749) | 3.24042239 |
29 | Abnormality of the nasal mucosa (HP:0000433) | 3.23148521 |
30 | Abnormality of T cells (HP:0002843) | 3.16697059 |
31 | Leukocytosis (HP:0001974) | 3.11923628 |
32 | Urticaria (HP:0001025) | 3.09992092 |
33 | Pulmonary infiltrates (HP:0002113) | 3.07284547 |
34 | Panhypogammaglobulinemia (HP:0003139) | 3.00418944 |
35 | Hemoptysis (HP:0002105) | 2.97034059 |
36 | Facial diplegia (HP:0001349) | 2.96878325 |
37 | Gingival bleeding (HP:0000225) | 2.88042772 |
38 | Granulocytopenia (HP:0001913) | 2.87896188 |
39 | Systemic lupus erythematosus (HP:0002725) | 2.83701405 |
40 | Polycythemia (HP:0001901) | 2.81091253 |
41 | Hypoglycemic coma (HP:0001325) | 2.75110542 |
42 | Asymmetric septal hypertrophy (HP:0001670) | 2.73980232 |
43 | Peritonitis (HP:0002586) | 2.73704181 |
44 | Right ventricular cardiomyopathy (HP:0011663) | 2.72312872 |
45 | Episodic fever (HP:0001954) | 2.71588830 |
46 | Myoglobinuria (HP:0002913) | 2.70720236 |
47 | Aortic dissection (HP:0002647) | 2.68112705 |
48 | Pulmonary embolism (HP:0002204) | 2.66003830 |
49 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.60443790 |
50 | Interstitial pulmonary disease (HP:0006530) | 2.59551671 |
51 | Increased connective tissue (HP:0009025) | 2.58795025 |
52 | Oligomenorrhea (HP:0000876) | 2.58505242 |
53 | Colitis (HP:0002583) | 2.56218756 |
54 | Eosinophilia (HP:0001880) | 2.54092346 |
55 | Vacuolated lymphocytes (HP:0001922) | 2.53759226 |
56 | Hypochromic microcytic anemia (HP:0004840) | 2.53142017 |
57 | Prolonged bleeding time (HP:0003010) | 2.50613154 |
58 | Broad metatarsal (HP:0001783) | 2.49884274 |
59 | Hypochromic anemia (HP:0001931) | 2.49097336 |
60 | Increased IgM level (HP:0003496) | 2.48100067 |
61 | Osteomyelitis (HP:0002754) | 2.46085057 |
62 | Agammaglobulinemia (HP:0004432) | 2.43519663 |
63 | Anorexia (HP:0002039) | 2.41060373 |
64 | Thrombocytosis (HP:0001894) | 2.39823443 |
65 | Aneurysm (HP:0002617) | 2.37286176 |
66 | Lymphopenia (HP:0001888) | 2.37016918 |
67 | Complement deficiency (HP:0004431) | 2.36482041 |
68 | Growth hormone excess (HP:0000845) | 2.35829351 |
69 | Abnormality of T cell physiology (HP:0011840) | 2.35709427 |
70 | Inflammation of the large intestine (HP:0002037) | 2.34989455 |
71 | Sepsis (HP:0100806) | 2.34886646 |
72 | Amyloidosis (HP:0011034) | 2.34615263 |
73 | Ankle contracture (HP:0006466) | 2.33874693 |
74 | Abnormality of eosinophils (HP:0001879) | 2.33669552 |
75 | Papilledema (HP:0001085) | 2.32336452 |
76 | Acanthosis nigricans (HP:0000956) | 2.31316432 |
77 | Gastrointestinal inflammation (HP:0004386) | 2.30880824 |
78 | Rhabdomyolysis (HP:0003201) | 2.30619002 |
79 | Eczematoid dermatitis (HP:0000976) | 2.29363441 |
80 | Increased cerebral lipofuscin (HP:0011813) | 2.28297754 |
81 | Nasal polyposis (HP:0100582) | 2.27935003 |
82 | Dysostosis multiplex (HP:0000943) | 2.27858893 |
83 | Abnormality of the pleura (HP:0002103) | 2.27370718 |
84 | Hypertriglyceridemia (HP:0002155) | 2.26441070 |
85 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.25904753 |
86 | Verrucae (HP:0200043) | 2.25668843 |
87 | Papilloma (HP:0012740) | 2.25668843 |
88 | Hypergammaglobulinemia (HP:0010702) | 2.23632434 |
89 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.22694935 |
90 | Gangrene (HP:0100758) | 2.22337059 |
91 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.20919892 |
92 | Abnormality of the peritoneum (HP:0002585) | 2.19849865 |
93 | Rectal prolapse (HP:0002035) | 2.18052339 |
94 | Ventricular tachycardia (HP:0004756) | 2.16553517 |
95 | Difficulty running (HP:0009046) | 2.16544177 |
96 | Viral hepatitis (HP:0006562) | 2.15546855 |
97 | Glomerulonephritis (HP:0000099) | 2.14935768 |
98 | Myositis (HP:0100614) | 2.14791813 |
99 | Generalized aminoaciduria (HP:0002909) | 2.14267308 |
100 | Fatigue (HP:0012378) | 2.14210443 |
101 | Microcytic anemia (HP:0001935) | 2.13963874 |
102 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.13471859 |
103 | Chronic otitis media (HP:0000389) | 2.13437236 |
104 | Type 1 muscle fiber predominance (HP:0003803) | 2.13324714 |
105 | Mucopolysacchariduria (HP:0008155) | 2.10492347 |
106 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.10492347 |
107 | Subacute progressive viral hepatitis (HP:0006572) | 2.09443448 |
108 | Esophageal varix (HP:0002040) | 2.09233326 |
109 | Slow saccadic eye movements (HP:0000514) | 2.07603818 |
110 | Insulin resistance (HP:0000855) | 2.06591765 |
111 | Abnormality of the endocardium (HP:0004306) | 2.06146986 |
112 | Nephritis (HP:0000123) | 2.05877213 |
113 | Skin ulcer (HP:0200042) | 2.05214568 |
114 | IgM deficiency (HP:0002850) | 2.04092674 |
115 | Acute hepatic failure (HP:0006554) | 2.03802422 |
116 | Autoimmune hemolytic anemia (HP:0001890) | 2.03122723 |
117 | Bone cyst (HP:0012062) | 2.03006467 |
118 | Vertigo (HP:0002321) | 2.02016540 |
119 | Ketoacidosis (HP:0001993) | 2.01447675 |
120 | Glomerulopathy (HP:0100820) | 2.00544659 |
121 | Striae distensae (HP:0001065) | 1.99180537 |
122 | Keratitis (HP:0000491) | 1.99065168 |
123 | Severe combined immunodeficiency (HP:0004430) | 1.99036410 |
124 | Autoimmune thrombocytopenia (HP:0001973) | 1.98012395 |
125 | Spondylolisthesis (HP:0003302) | 1.96642394 |
126 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.96307516 |
127 | Arterial tortuosity (HP:0005116) | 1.94783640 |
128 | Ulnar deviation of the wrist (HP:0003049) | 1.94361979 |
129 | Impaired platelet aggregation (HP:0003540) | 1.94289534 |
130 | Abnormal platelet function (HP:0011869) | 1.94289534 |
131 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.93922882 |
132 | Osteolytic defects of the hand bones (HP:0009699) | 1.93268761 |
133 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.93268761 |
134 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.91523778 |
135 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.91523778 |
136 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.91523778 |
137 | Recurrent bronchitis (HP:0002837) | 1.90623153 |
138 | Hemorrhage of the eye (HP:0011885) | 1.90180407 |
139 | Bicuspid aortic valve (HP:0001647) | 1.89790858 |
140 | Hyporeflexia of lower limbs (HP:0002600) | 1.89361805 |
141 | IgG deficiency (HP:0004315) | 1.89341230 |
142 | Enlarged penis (HP:0000040) | 1.89156892 |
143 | Acne (HP:0001061) | 1.88639590 |
144 | Lipoatrophy (HP:0100578) | 1.87440667 |
145 | Hyperglycinuria (HP:0003108) | 1.85999860 |
146 | Joint swelling (HP:0001386) | 1.84580771 |
147 | Stomach cancer (HP:0012126) | 1.84495229 |
148 | Recurrent abscess formation (HP:0002722) | 1.83940389 |
149 | Mitral valve prolapse (HP:0001634) | 1.83903330 |
150 | Cardiomegaly (HP:0001640) | 1.83617408 |
151 | Skin rash (HP:0000988) | 1.83576082 |
152 | Muscle fiber splitting (HP:0003555) | 1.82361186 |
153 | Thin bony cortex (HP:0002753) | 1.82296237 |
154 | Epistaxis (HP:0000421) | 1.81233064 |
155 | Petechiae (HP:0000967) | 1.81214227 |
156 | Exercise-induced myalgia (HP:0003738) | 1.80701864 |
157 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.80498957 |
158 | Pustule (HP:0200039) | 1.80196990 |
159 | Abnormal platelet volume (HP:0011876) | 1.79728527 |
160 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.78348694 |
161 | Recurrent viral infections (HP:0004429) | 1.76725373 |
162 | Arterial thrombosis (HP:0004420) | 1.74819560 |
163 | Myocardial infarction (HP:0001658) | 1.73891117 |
164 | Cellulitis (HP:0100658) | 1.73507182 |
165 | Vascular tortuosity (HP:0004948) | 1.73313391 |
166 | Abnormality of the fingertips (HP:0001211) | 1.70052991 |
167 | Emphysema (HP:0002097) | 1.69887642 |
168 | Visceral angiomatosis (HP:0100761) | 1.68948794 |
169 | Gastrointestinal stroma tumor (HP:0100723) | 1.67024583 |
170 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.66670106 |
171 | Dicarboxylic aciduria (HP:0003215) | 1.66670106 |
172 | Abnormality of complement system (HP:0005339) | 1.65967940 |
173 | Increased IgE level (HP:0003212) | 1.65753128 |
174 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.65488479 |
175 | Exercise-induced muscle cramps (HP:0003710) | 1.64380039 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 4.22546108 |
2 | TGFBR2 | 3.94402890 |
3 | TRIB3 | 3.63576012 |
4 | PKN2 | 3.26101570 |
5 | ERN1 | 2.91229204 |
6 | BLK | 2.78761590 |
7 | TIE1 | 2.75180758 |
8 | EEF2K | 2.65948136 |
9 | PRPF4B | 2.58353375 |
10 | FES | 2.54067681 |
11 | GRK6 | 2.45755510 |
12 | IRAK4 | 2.29046533 |
13 | FLT3 | 2.27870363 |
14 | TXK | 2.18308635 |
15 | CAMK1D | 2.15389943 |
16 | MAP4K1 | 2.15291662 |
17 | TTN | 2.13189302 |
18 | MAP2K3 | 2.00234267 |
19 | BCKDK | 1.98562539 |
20 | MAPK15 | 1.82623021 |
21 | RIPK1 | 1.79898350 |
22 | TNK2 | 1.77887722 |
23 | TYK2 | 1.77294196 |
24 | TGFBR1 | 1.76646855 |
25 | JAK3 | 1.70592593 |
26 | FGFR4 | 1.66096997 |
27 | KDR | 1.64241488 |
28 | MAP3K14 | 1.58019809 |
29 | MAP3K13 | 1.56235005 |
30 | PTK6 | 1.51430891 |
31 | LRRK2 | 1.50442898 |
32 | SIK1 | 1.49696272 |
33 | MAPKAPK3 | 1.48730357 |
34 | STK10 | 1.48027368 |
35 | KIT | 1.45681602 |
36 | ZAP70 | 1.39223048 |
37 | PIK3CG | 1.38424296 |
38 | CAMK1G | 1.37265734 |
39 | FGR | 1.36739599 |
40 | JAK1 | 1.36299541 |
41 | LYN | 1.31886312 |
42 | EPHB1 | 1.30346065 |
43 | MYLK | 1.29994338 |
44 | TBK1 | 1.29941911 |
45 | FGFR3 | 1.24245071 |
46 | KSR2 | 1.23108875 |
47 | YES1 | 1.22408846 |
48 | TAOK3 | 1.22017366 |
49 | TAOK1 | 1.20696375 |
50 | SIK3 | 1.19757207 |
51 | BTK | 1.18998096 |
52 | MAP3K10 | 1.18249598 |
53 | CSF1R | 1.16480706 |
54 | MAP3K3 | 1.14143052 |
55 | LMTK2 | 1.10125419 |
56 | MARK2 | 1.09709731 |
57 | MARK3 | 1.02916302 |
58 | MAP3K6 | 1.02573631 |
59 | PAK4 | 1.01988194 |
60 | IKBKE | 1.01363392 |
61 | INSRR | 0.99661489 |
62 | MAP3K11 | 0.98693925 |
63 | RPS6KB2 | 0.98026805 |
64 | JAK2 | 0.94293032 |
65 | FRK | 0.94205193 |
66 | TEC | 0.93254055 |
67 | ITK | 0.92965004 |
68 | CDK6 | 0.92788423 |
69 | CSK | 0.90961278 |
70 | BMPR2 | 0.90335692 |
71 | NLK | 0.88019713 |
72 | PRKAA2 | 0.87396462 |
73 | PDGFRA | 0.83734690 |
74 | CDK9 | 0.83528608 |
75 | IRAK1 | 0.82220733 |
76 | NEK9 | 0.81880272 |
77 | MAPK7 | 0.80211728 |
78 | MAP3K7 | 0.78973865 |
79 | TRPM7 | 0.76358291 |
80 | MAP2K2 | 0.76233989 |
81 | CAMKK2 | 0.74991542 |
82 | EPHA3 | 0.74909602 |
83 | SGK3 | 0.74614187 |
84 | SGK2 | 0.73985862 |
85 | MATK | 0.72794581 |
86 | SIK2 | 0.71334728 |
87 | PDK2 | 0.70729811 |
88 | IRAK3 | 0.70140515 |
89 | FYN | 0.68005437 |
90 | MST1R | 0.67875251 |
91 | DMPK | 0.67597832 |
92 | PDK3 | 0.67240433 |
93 | PDK4 | 0.67240433 |
94 | PRKG2 | 0.66076134 |
95 | RET | 0.64981335 |
96 | PRKCQ | 0.63572674 |
97 | STK38 | 0.63270925 |
98 | PIK3CA | 0.63266839 |
99 | PDPK1 | 0.63171812 |
100 | CAMKK1 | 0.62737849 |
101 | LCK | 0.61765690 |
102 | PTK2B | 0.58957789 |
103 | PAK2 | 0.58944452 |
104 | IKBKB | 0.57543515 |
105 | PDGFRB | 0.56842915 |
106 | HCK | 0.56407389 |
107 | HIPK2 | 0.56036524 |
108 | SCYL2 | 0.54852863 |
109 | PASK | 0.53635469 |
110 | MAPK11 | 0.52003276 |
111 | CHUK | 0.51702182 |
112 | CDK19 | 0.51658539 |
113 | PRKD1 | 0.51583019 |
114 | LATS1 | 0.51471091 |
115 | ILK | 0.51138769 |
116 | RAF1 | 0.50913188 |
117 | PIM1 | 0.50645530 |
118 | STK11 | 0.50589819 |
119 | MAP2K4 | 0.50282143 |
120 | RPS6KA4 | 0.50024078 |
121 | PRKD2 | 0.49687985 |
122 | MAP3K2 | 0.49424949 |
123 | MTOR | 0.48653935 |
124 | CDC42BPA | 0.47883640 |
125 | IRAK2 | 0.46449359 |
126 | OBSCN | 0.46307286 |
127 | MAP3K5 | 0.44565079 |
128 | CDK4 | 0.44295190 |
129 | TESK2 | 0.43815942 |
130 | NME2 | 0.42795483 |
131 | CDK12 | 0.42464549 |
132 | SGK494 | 0.42150645 |
133 | SGK223 | 0.42150645 |
134 | MAPK12 | 0.40438241 |
135 | RPS6KA6 | 0.39415072 |
136 | MAP3K1 | 0.38958830 |
137 | SYK | 0.38561980 |
138 | PDK1 | 0.38350018 |
139 | TAOK2 | 0.37759899 |
140 | MAP2K6 | 0.37685302 |
141 | KSR1 | 0.37563573 |
142 | IGF1R | 0.37183301 |
143 | RPS6KC1 | 0.37021991 |
144 | RPS6KL1 | 0.37021991 |
145 | DYRK1B | 0.36762264 |
146 | PRKCH | 0.35127420 |
147 | MAPKAPK2 | 0.35014177 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.61462027 |
2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.44624725 |
3 | Allograft rejection_Homo sapiens_hsa05330 | 2.35944548 |
4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.30222156 |
5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.27200120 |
6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.19837222 |
7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.01249645 |
8 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.00771410 |
9 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.00474484 |
10 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.91916698 |
11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.91288982 |
12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.75664979 |
13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74097932 |
14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.68750225 |
15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64863006 |
16 | Insulin resistance_Homo sapiens_hsa04931 | 1.63076728 |
17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.61140344 |
18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.59285111 |
19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.56339093 |
20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.53486269 |
21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52220218 |
22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50041427 |
23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.49353428 |
24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.48057603 |
25 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.44835142 |
26 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.43109470 |
27 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.33397893 |
28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.31479115 |
29 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.31343897 |
30 | Platelet activation_Homo sapiens_hsa04611 | 1.31174953 |
31 | Lysosome_Homo sapiens_hsa04142 | 1.27096308 |
32 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.22923378 |
33 | Focal adhesion_Homo sapiens_hsa04510 | 1.20877407 |
34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19453698 |
35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.18428013 |
36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16955828 |
37 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.14958611 |
38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.14119669 |
39 | Phagosome_Homo sapiens_hsa04145 | 1.13883689 |
40 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.13364526 |
41 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.13088744 |
42 | Measles_Homo sapiens_hsa05162 | 1.11378631 |
43 | Asthma_Homo sapiens_hsa05310 | 1.08196048 |
44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.07441259 |
45 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.03959629 |
46 | ABC transporters_Homo sapiens_hsa02010 | 1.02182455 |
47 | Pertussis_Homo sapiens_hsa05133 | 0.99786588 |
48 | Lysine degradation_Homo sapiens_hsa00310 | 0.99710469 |
49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.98559321 |
50 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.97491190 |
51 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.95455032 |
52 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.95409182 |
53 | Adherens junction_Homo sapiens_hsa04520 | 0.95058132 |
54 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.94740091 |
55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.94439882 |
56 | Legionellosis_Homo sapiens_hsa05134 | 0.94369417 |
57 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93399238 |
58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.92938811 |
59 | Influenza A_Homo sapiens_hsa05164 | 0.92180293 |
60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.91020054 |
61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.89754316 |
62 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89730891 |
63 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89347411 |
64 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.88814328 |
65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86602919 |
66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.85636660 |
67 | Endometrial cancer_Homo sapiens_hsa05213 | 0.84762673 |
68 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82392580 |
69 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.82376021 |
70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81433461 |
71 | Malaria_Homo sapiens_hsa05144 | 0.80705445 |
72 | Carbon metabolism_Homo sapiens_hsa01200 | 0.80472125 |
73 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.79762531 |
74 | Amoebiasis_Homo sapiens_hsa05146 | 0.79475987 |
75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79299319 |
76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78752842 |
77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78060309 |
78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.77735585 |
79 | Shigellosis_Homo sapiens_hsa05131 | 0.77340699 |
80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76759999 |
81 | Endocytosis_Homo sapiens_hsa04144 | 0.76663679 |
82 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.74749362 |
83 | Apoptosis_Homo sapiens_hsa04210 | 0.73806964 |
84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73438570 |
85 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.73095797 |
86 | Hepatitis C_Homo sapiens_hsa05160 | 0.72883997 |
87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72411739 |
88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.71629482 |
89 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.71511434 |
90 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.70862074 |
91 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.70515644 |
92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68976353 |
93 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68532576 |
94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.68171770 |
95 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.68087399 |
96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68075991 |
97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67606059 |
98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67356651 |
99 | Salmonella infection_Homo sapiens_hsa05132 | 0.67288773 |
100 | Colorectal cancer_Homo sapiens_hsa05210 | 0.67207484 |
101 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66356546 |
102 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.66227882 |
103 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.65193042 |
104 | Thyroid cancer_Homo sapiens_hsa05216 | 0.63943456 |
105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63296741 |
106 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63296520 |
107 | Hepatitis B_Homo sapiens_hsa05161 | 0.62595576 |
108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62303003 |
109 | Tuberculosis_Homo sapiens_hsa05152 | 0.62179912 |
110 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59902512 |
111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59595805 |
112 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59407595 |
113 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.58774366 |
114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58722443 |
115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58463111 |
116 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.58441817 |
117 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.58121842 |
118 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57979820 |
119 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57005370 |
120 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56017480 |
121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54501654 |
122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53955255 |
123 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.53697425 |
124 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53631717 |
125 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53310785 |
126 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52426998 |
127 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52234506 |
128 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51211972 |
129 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49910459 |
130 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49894234 |
131 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.49220598 |
132 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48684124 |
133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48670408 |
134 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.47096524 |
135 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47024570 |
136 | Prostate cancer_Homo sapiens_hsa05215 | 0.46694797 |
137 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.46629288 |
138 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45709424 |
139 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44990314 |
140 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44937045 |
141 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44883754 |
142 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.44316983 |
143 | Long-term potentiation_Homo sapiens_hsa04720 | 0.44027489 |
144 | Glioma_Homo sapiens_hsa05214 | 0.41183777 |